These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1978546)

  • 1. Beta-blocker duration of action and implications for therapy.
    Kostis JB
    Am J Cardiol; 1990 Nov; 66(16):60G-62G. PubMed ID: 1978546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris.
    Kostis JB
    Am J Cardiol; 1988 Dec; 62(17):1171-5. PubMed ID: 3057850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
    Wilcox RG; Hampton JR
    Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
    Wolfel EE; Hiatt WR; Brammell HL; Carry MR; Ringel SP; Travis V; Horwitz LD
    Circulation; 1986 Oct; 74(4):664-74. PubMed ID: 2875812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
    Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
    Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.
    Channer KS; James MA; MacConnell T; Rees JR
    Br J Clin Pharmacol; 1994 Jan; 37(1):53-7. PubMed ID: 7908532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta blocker effects on heart rate during sleep: a placebo-controlled polysomnographic study with normotensive males.
    Rosen RC; Kostis JB; Seltzer LG; Taska LS; Holzer BC
    Sleep; 1991 Feb; 14(1):43-7. PubMed ID: 1687425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris.
    Schwartz JB; Jackson G; Kates RE; Harrison DC
    Am Heart J; 1981 Apr; 101(4):380-5. PubMed ID: 6111212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect on heart rate variability of some agents acting at the beta-adrenoceptor using nonlinear scatterplot and sequence methods.
    Silke B; Riddell JG
    Cardiovasc Drugs Ther; 1998 Oct; 12(5):439-48. PubMed ID: 9926274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.